About

ROSUFIT F 10 combines Rosuvastatin, a highly effective HMG-CoA reductase inhibitor, with Fenofibrate, a potent fibric acid derivative. Rosuvastatin primarily targets and significantly lowers low-density lipoprotein cholesterol (LDL-C) and total cholesterol, playing a critical role in reducing atherosclerotic plaque burden. Fenofibrate, on the other hand, is particularly effective at reducing elevated triglyceride levels and increasing beneficial high-density lipoprotein cholesterol (HDL-C) by activating peroxisome proliferator-activated receptor alpha (PPARα). This dual-action combination therapy is specifically designed for patients with complex mixed dyslipidemia who require comprehensive lipid management, especially those presenting with both high triglycerides and elevated LDL-C. By addressing multiple lipid abnormalities simultaneously, ROSUFIT F 10 aims to provide enhanced cardiovascular protection and reduce the overall risk of cardiovascular events in this high-risk patient population.

Uses

Mixed dyslipidemia with elevated triglycerides and LDL-C.
Hypertriglyceridemia not adequately controlled by monotherapy.
Primary hypercholesterolemia with significant hypertriglyceridemia.
Prevention of cardiovascular events in high-risk patients with mixed dyslipidemia.

Directions For Use

Take orally once daily, preferably with a meal to enhance absorption of fenofibrate, or as advised by your doctor.

Benefits

Comprehensive reduction of LDL-C, total cholesterol, and triglycerides.
Significant increase in beneficial HDL-C.
Addresses multiple lipid abnormalities simultaneously.
Reduces the risk of pancreatitis associated with very high triglycerides.
Provides enhanced cardiovascular protection.
Offers a convenient single-pill option for complex dyslipidemia.

Side Effects

Muscle pain (myalgia)
Headache
Nausea
Abdominal pain
Elevated liver enzymes
Gallstones (cholelithiasis)
Pancreatitis
Rash
Fatigue
Dizziness
Constipation
Increased creatinine levels

Safety Measures

Alcohol - Avoid excessive alcohol consumption as it can increase the risk of liver damage and muscle side effects, especially with fenofibrate.
Pregnancy - Contraindicated in pregnancy due to potential fetal harm. Ensure effective contraception is used.
Breastfeeding - Not recommended during breastfeeding as both components may pass into breast milk.
Liver - Contraindicated in active liver disease. Regular monitoring of liver function tests is crucial.
Kidney - Contraindicated in severe renal impairment. Dosage adjustment is required for moderate impairment.
Lung - Generally safe for use in patients with lung conditions; no specific contraindications related to lung health.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location